FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Faron Pharmaceuticals: Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board
Convertible bond amortization payment deferred by mutual agreement with HCM
Issuance of warrants
HOLDING(S) IN COMPANY
HOLDING(S) IN COMPANY
HOLDING(S) IN COMPANY
Half-year financial results 1 January – 30 June 2026
Notice of Half-Year Financial Results
HOLDING(S) IN COMPANY
HOLDING(S) IN COMPANY
Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First and Second Tranche Bonds
Faron Pharmaceuticals: Inside Information: Faron announces encouraging first overall survival data from frontline higher-risk (HR) MDS patients in the BEXMAB phase 1/2 trial
HOLDING(S) IN COMPANY
Grant of Options
HOLDING(S) IN COMPANY
HOLDING(S) IN COMPANY
HOLDING(S) IN COMPANY
HOLDING(S) IN COMPANY
HOLDING(S) IN COMPANY